Deepak Khanna is Senior Vice President and Regional President, EMEAC Oncology for MSD. Deepak took on this new role in January 2014 and is responsible for developing MSD & Merck’s oncology capabilities across Europe
Prior to this role, Deepak was SVP and Managing Director of MSD UK and Ireland from 2009-2013, a role which included the integration of MSD with Schering-Plough.
Alongside his role as UK Managing Director, Deepak played an active role in pharmaceutical industry affairs. He held the position of President of the Association of the British Pharmaceutical Industry (ABPI) between April 2012 and April 2014 and oversaw the pricing and reimbursement negotiations with the UK government during his tenure. Prior to this, he was Chair of the American Pharmaceutical Group (APG).
Deepak began his career at Merck in 1988 in field sales and progressed to positions of increasing responsibility within the U.S. and Worldwide Human Health Division. His career has included roles as Vice President and General Manager of Merck/Schering-Plough Pharmaceuticals. He managed all aspects of the U.S. Merck/Schering-Plough Joint Venture and was responsible for the U.S. marketing and sales for the two cardiovascular products jointly marketed by the two companies. After the announcement of plans to merge with Schering-Plough (March 2009), Mr Khanna also led the U.S. integration planning efforts.
In 1996, Deepak joined the Worldwide Human Health Marketing Division working with rheumatology products; he later assumed responsibility for the marketing planning activities to support early stage central nervous system products. Deepak rejoined the U.S. Human Health Division in 2001 and assumed leadership responsibilities of the Migraine Franchise Business Group. In January 2003, he was promoted to Vice President of the Atherosclerosis Franchise Business Group.
Deepak holds dual nationality, both British and American. He earned a Bachelor’s degree in biochemistry and economics from the University of California, Berkeley and an MBA in marketing from Santa Clara University.